Driving Rho GTPase activity in endothelial cells regulates barrier integrity

Journal:Thrombosis and Haemostasis
ISSN:0340-6245
DOI:http://dx.doi.org/10.1160/TH09-06-0403
Issue:2010: 103/1 (Jan) pp. 1–249
Pages:40-55

Driving Rho GTPase activity in endothelial cells regulates barrier integrity

C. M. L. Beckers (1), V. W. M. van Hinsbergh (1), G. P. van Nieuw Amerongen (1)
(1) Department for Physiology, VU University Medical Center, Institute for Cardiovascular Research, Amsterdam, the Netherlands

Summary

In the past decade understanding of the role of the Rho GTPases RhoA, Rac1 and Cdc42 has been developed from regulatory proteins that regulate specific actin cytoskeletal structures – stress fibers, lamellipodia and filopodia – to complex integrators of cytoskeletal structures that can exert multiple functions depending on the cellular context. Fundamental to these functions are three-dimensional complexes between the individual Rho GTPases, their specific activators (GEFs) and inhibitors (GDIs and GAPs), which greatly outnumber the Rho GTPases themselves, and additional regulatory proteins. By this complexity of regulation different vasoactive mediators can induce various cytoskeletal structures that enable the endothelial cell (EC) to respond adequately. In this review we have focused on this complexity and the consequences of Rho GTPase regulation for endothelial barrier function. The permeability inducers thrombin and VEGF are presented as examples of G-protein coupled receptor- and tyrosine kinase receptor-mediated Rho GTPase activation, respectively. These mediators induce complex but markedly different networks of activators, inhibitors and effectors of Rho GTPases, which alter the endothelial barrier function. An interesting feature in this regulation is that Rho GTPases often have both barrier-protecting and barrier-disturbing functions. While Rac1 enforces the endothelial junctions, it becomes part of a barrier-disturbing mechanism as activator of reactive oxygen species generating NADPH oxidase. Similarly RhoA is protective under basal conditions, but becomes involved in barrier dysfunction after activation of ECs by thrombin. The challenge and promise lies in unfolding this complex regulation, as this will provide leads for new therapeutic opportunities.

Keywords

endothelial cells, protein function / activity, cell-cell interactions, GTPases, cytoskeleton

DOI

http://dx.doi.org/10.1160/TH09-06-0403

You may also be interested in...

1.

Valeria V. Orlova, Triantafyllos Chavakis

Thrombosis and Haemostasis 2007 98 2: 327-332

http://dx.doi.org/10.1160/TH07-03-0206

2.

Emmanouil Chavakis1; Eun Young Choi2; Triantafyllos Chavakis2

Thrombosis and Haemostasis 2009 102 2: 191-197

http://dx.doi.org/10.1160/TH08-12-0844

3.

Laura Barberis, Emilio Hirsch

Thrombosis and Haemostasis 2008 99 2: 279-285

http://dx.doi.org/10.1160/TH07-10-0632



Articles

You've 110 Article(s) in your Basket.

TH 107.5

Clinical Focus on GPIIb/IIIa inhibitors: In the May issue of Thrombosis and Haemostasis Armstrong...

TH 107.4

The April 2012 issue of Thrombosis and Haemostasis TH 107.4 is a Theme Issue by A. Schober, T....

Thrombosis and Haemostasis official organ of Spanish Society for Thrombosis and Haemostasis

Thrombosis and Haemostasis, founded in 1957, has become the official organ of the Spanish Society...